Prudential plc’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Prudential plc's ARKG Position: Q1 2026 in Review
Prudential plc reduced its ARK Genomic Revolution ETF (ARKG) stake by 12% in Q1 2026, selling an estimated $167K and leaving 42,070 shares worth $1.11M. The position accounts for 0.01% of the portfolio, ranked #461.
Prudential plc first reported a position in ARKG in Q2 2020 and has held it in 23 quarters since. The position peaked at $11.1M in Q2 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.
- Prudential plc held 42,070 shares of ARK Genomic Revolution ETF worth $1.11M as of Q1 2026.
- Prudential plc sold 5,700 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $167K.
- ARK Genomic Revolution ETF made up 0.01% of Prudential plc's portfolio in Q1 2026, its #461 holding.
- Prudential plc first reported a position in ARK Genomic Revolution ETF in Q2 2020 and has held it in 23 quarters since.
- Prudential plc's ARK Genomic Revolution ETF position peaked at $11.1M in Q2 2021.
- 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.
Based on Prudential plc's 13F filing for Q1 2026, filed 14 May 2026.